Aprea Therapeutics
Price & Volume
Stats
See more52W Range | $0.54-$2.22 |
Market Cap | $9.8M |
Shares Short | 109,910 |
Financials
See moreRevenue (12 Mos) | $285,759 |
Revenue Growth (YoY) | -98.4% |
Gross Profit (12 Mos) | -$6.7M |
Diluted EPS | -$1.93 |
News
See moreYahoo Finance • 14 days ago
Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting
Yahoo Finance • 2 months ago
Aprea Therapeutics GAAP EPS of -$0.32 beats by $0.07
Yahoo Finance • 5 months ago
Aprea Therapeutics CEO Issues Letter to Shareholders Highlighting Pipeline Progress in 2025 and Outlook for 2026
Yahoo Finance • 6 months ago
Aprea Therapeutics GAAP EPS of -$0.47, revenue of $1.84M
About
CEO | Dr. Oren Gilad Ph.D. |
CFO | Mr. John P. Hamill C.P.A. |
Address | 3805 Old Easton Road, Doylestown, PA, United States, 18902 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 8 |